Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the efficacy and safety of high-intensity rosuvastatin and moderate-intensity rosuvastatin/ezetimibe in ASCVD patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03494270
Study type Interventional
Source Yuhan Corporation
Contact
Status Completed
Phase Phase 4
Start date March 18, 2018
Completion date September 26, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05390892 - PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes Phase 4
Active, not recruiting NCT05088759 - Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management N/A
Not yet recruiting NCT04093440 - Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes N/A
Recruiting NCT05611307 - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed NCT03400800 - Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol Phase 3
Recruiting NCT03606824 - Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) N/A
Recruiting NCT05579626 - Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) N/A
Recruiting NCT06005597 - Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies Phase 3
Active, not recruiting NCT06295861 - Prospective Cohort Study of Panvascular Disease
Terminated NCT04197453 - The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
Completed NCT03399370 - Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol Phase 3
Not yet recruiting NCT05976893 - Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer Phase 4
Completed NCT03474562 - High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension Phase 4
Completed NCT03814187 - Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C Phase 3
Not yet recruiting NCT05858879 - Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD) N/A